BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 17567872)

  • 1. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
    Podnos YD; Smith D; Wagman LD; Ellenhorn JD
    Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
    Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
    Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of treatment options for papillary microcarcinoma of the thyroid.
    Lin HW; Bhattacharyya N
    Laryngoscope; 2009 Oct; 119(10):1983-7. PubMed ID: 19655332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
    Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
    Brierley J; Tsang R; Panzarella T; Bana N
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
    Farahati J; Mörtl M; Reiners C
    Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 17. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
    Zaydfudim V; Feurer ID; Griffin MR; Phay JE
    Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma.
    Yamashita H; Noguchi S; Murakami N; Kawamoto H; Watanabe S
    Cancer; 1997 Dec; 80(12):2268-72. PubMed ID: 9404704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.